Filing Flows › Harvard Apparatus Regenerative Technology (HRGN) › Q2 2025
Harvard Apparatus Regenerative Technology (HRGN) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 11, 2025
Harvard Apparatus Regenerative Technology (HRGN) reported revenue of $317K for the second quarter 2025 (Q2 2025), +466% from a year earlier and +604% from the quarter before. Operating margin was -578.2%, net loss $1.8M (575.1% of revenue).
Harvard Apparatus Regenerative Technology, Q2 2025: revenue $317K (+466% year over year), operating margin -578.2%, net loss $1.8M, operating cash flow −$941K. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $317K | +604% | +466% |
| Operating profit | −$1.8M | — | — |
| Net earnings | −$1.8M | — | — |
| Operating cash flow | −$941K | — | — |
What changed
Revenue was $317K in Q2 2025, up 466% year over year and up 604% from the previous quarter.
Operating costs exceeded revenue by $1.8M, an operating margin of -578.2%. Total costs fell 15% while revenue rose 466%. The fastest-growing cost line was Cost of revenue (+2223%). The quarter ended with a net loss of $1.8M, wider than the previous quarter's $1.7M loss.
Operating cash flow was −$941K. Non-cash charges added back $1K of depreciation and $537K of share-based compensation. Working capital and other items added $344K.
Questions
What was Harvard Apparatus Regenerative Technology's revenue in the second quarter 2025?
Harvard Apparatus Regenerative Technology (HRGN) reported revenue of $317K for the second quarter 2025 (Q2 2025), +466% from a year earlier and +604% from the quarter before.
Was Harvard Apparatus Regenerative Technology profitable in the second quarter 2025?
Operating loss was $1.8M (-578.2% of revenue) and net loss $1.8M.
Source: Harvard Apparatus Regenerative Technology 10-Q on SEC EDGAR.